서울특별시내과

The Liver Week 2026 Day 3

Name: The Liver Week 2026 Day 3
Start: 2026-06-13
End: 2026-06-13
Location: 콘래드 서울, Room 1AB, 1C, 2AB, 2C, 3, 4A

6점 일반 6

주최: 대한간학회
일자: 2026-06-13
장소: 콘래드 서울, Room 1AB, 1C, 2AB, 2C, 3, 4A
수강료: 210,000원

수강료 상세 안내

회원/비회원·전공의·사전/현장등록 등 상세 등록비는 KMA 신청 페이지에서 확인하세요.

평점 구성

총 평점6점

필수평점0점

일반평점6점

연수평점은 3년 24점·연 8점 상한·필수 2점 요건이 있습니다. 이 행사 들으면 올해 상한까지 몇 점? →

KMA 등록 페이지에서 신청 → 평점 계산기

세부 일정 (56강)

08:00~08:20 Expanding the Donor Pool: Donation after Circulatory Death, Donation after Brain Death, and Ex-vivo Graft Management Strategies Room 1AB Parissa Tabrizian(Icahn School of Medicine at Mount Sinai, USA)
08:20~08:40 Optimizing Allocation and Policy Models: Balancing Equity and Efficiency in Opt-in vs. Opt-out Systems Room 1AB Willscott Naugler(Oregon Health & Science Univ., USA)
08:40~09:00 Expanding Recipient Criteria for HCC: Lessons from Living Donor Liver Transplantation and Regional Experiences Room 1AB 홍석균(서울의대)
09:10~09:30 Outcomes and Prognosis in MASLD: Genetic Determinants from Single-Nucleotide Polymorphisms to Beyond Room 1AB Stefano Romeo(Karolinska Institutet, Sweden)
09:30~09:50 MASLD vs. MetALD: Interactions between Alcohol Intake and Metabolic Risk Factors Room 1AB 김상균(순천향의대)
09:50~10:10 Standardizing Histological Grading and Staging in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Clinical Trials: Consensus Position Statements from the International Pathology Group Room 1AB 박영년(연세의대)
10:10~10:30 Future of MASH Treatment: GLP-1/GIP Agonists, Resmetirom, and Beyond Room 1AB 전대원(한양의대)
10:50~11:20 Developing Drugs for Liver Fibrosis Room 1AB David A. Brenner(Sanford Burnham Prebys, USA)
11:20~12:20 Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver disease Room 1AB Joo Hyun Oh (Eulji University)
13:10~13:50 Management of Chronic Hepatitis B: 2026 KASL Update Room 1AB 김인희(전북의대)
13:50~14:10 ACLF across Definitions: Harmonizing Diagnostic Criteria and Organ Failure Assessment Room 1AB 김정희(한림의대)
14:10~14:30 Management of Acute Kidney Injury in ACLF: Current Evidence and Unmet Need Room 1AB Rakhi Maiwall(Institute of Liver and Biliary Sciences, India)
14:30~14:50 Achieving Recompensation in Cirrhosis: Evidence and Future Directions Room 1AB Yu Jun Wong(Duke-NUS Medical School, Singapore)
14:50~15:10 ACLF: Transplant before It’s Too Late Room 1AB 김동식(고려의대)
15:20~15:35 The Korean Association for the study of the Liver Debrief Room 1AB 조유리(국립암센터)
15:35~15:50 The Korean Liver Cancer Association Debrief Room 1AB 이한아(중앙의대)
15:50~16:05 The Korean Association of Hepato Biliary Pancreatic Surgery Debrief Room 1AB 오남기(성균관의대)
16:05~16:20 The Korean Liver Transplantation Society Debrief Room 1AB 홍석균(서울의대)
09:10~09:30 Antisense Oligonucleotides vs. siRNA: Which Represents the Better Option for HBV Treatment? Room 1C Man-Fung Yuen(The Univ. of Hong Kong, Hong Kong)
09:30~09:50 Gene Therapies to Achieve Functional Cure in Chronic Hepatitis B Room 1C Edward Gane(Univ. of Auckland, New Zealand)
09:50~10:10 Do Capsid Inhibitors Have a Role in Achieving HBV Cure? Room 1C 안상훈(연세의대)
10:10~10:30 Endpoints of Chronic Hepatitis B Therapy: Partial, Functional, and Sterilizing Cure Room 1C Seng-Gee Lim(National Univ. of Singapore, Singapore)
13:50~14:20 Reversibility of Activated Portal Fibroblast in Cholestatic Liver Fibrosis Regression Room 1C Tatiana Kisseleva(Univ. of California San Diego, USA)
14:20~14:50 At the Frontline of Metabolic Liver Disease: Stress and Inflammation Room 1C Michael Karin(Sanford Burnham Prebys, USA)
14:50~15:10 Transcriptional Regulation of Hepatic Stellate Cell Phenotypes during Liver Fibrosis Resolution Room 1C 이원석(가천의대)
08:30~09:00 Stereotactic Body Radiation Therapy: Expert Consensus-based Practical Recommendations of KLCA Room 2AB 윤상민(울산의대)
09:10~09:30 Carbon Ion Therapy: The Next Step in Precision Radiotherapy Room 2AB Kei Shibuya(Gunma Univ., Japan)
09:30~09:50 Advances in Interventional Oncology: From TACE to TARE and Beyond Room 2AB 김경민(연세의대)
09:50~10:10 Novel Molecular and Cellular Therapies in HCC: The Next Wave Room 2AB Stephen Lam Chan(The Chinese Univ. of Hong Kong, Hong Kong)
10:10~10:30 Multidisciplinary Horizons: From Immune Checkpoint Blockade to Liver Transplantation Room 2AB Ju Dong Yang(Cedars-Sinai Medical Center, USA)
07:30~08:00 Ultrasound Assessment of Liver Fibrosis: Comparison with 2D Shear Wave Elastography and FibroScan Room 2C 유정주(순천향의대)
08:00~08:20 AI-Based Multi-Omics Integration for Precision Hepatology Room 2C 김준일(숭실대)
08:20~08:40 Deep Learning and Digital Pathology in HCC: From Diagnosis to Prognosis Room 2C 이성학(가톨릭의대)
08:40~09:00 Multimodal AI and Large Language Models for Cancer Research Room 2C 오승찬(연세의대)
09:10~09:30 Update on Clinical Trial Design and Endpoints in Alcohol-Associated Liver Disease Room 2C 남희철(가톨릭의대)
09:30~09:50 Immune Dysfunction in Alcohol-Associated Liver Disease Room 2C 서원효(이화의대)
09:50~10:10 Gut–Liver Axis in Alcohol-Associated Liver Disease: Mechanistic Insights and Translational Implications Room 2C 석기태(한림의대)
10:10~10:30 Discussion Room 2C
13:50~14:10 MASH Pathogenesis through Single-Cell Analysis Room 2C 최무림(서울의대)
14:10~14:30 Liver Organoid Model for Investigating SLD Room 2C 김요한(성균관대)
14:30~14:55 Advances in SLD Diagnosis Using 3D Multiparametric Imaging Room 2C 김철홍(POSTECH)
14:55~15:10 Discussion Room 2C
07:30~07:50 Resection Beyond BCLC Guidelines: Surgical Outcomes in BCLC B or C Room 3 윤영철(가톨릭의대)
07:50~08:10 Bridging with Locoregional Therapy: Role of TARE, TACE in Downstaging Room 3 현동호(성균관의대)
08:10~08:30 From Unresectable to Resectable: How Immunotherapy Is Changing the Surgical Landscape Room 3 유정주(순천향의대)
08:30~08:50 Surgical Considerations after Neoadjuvant or Conversion Therapy Room 3 Kiyoshi Hasegawa(The Univ. of Tokyo, Japan)
09:10~09:30 Why Surgeons Need AI: A Clinical Perspective Room 3 오남기(성균관의대)
09:30~09:50 Augmented Reality for Preoperative Planning and Intraoperative Visualization Room 3 Maki Sugimoto(Teikyo Univ. Okinaga Research Institute, Japan)
09:50~10:10 Real-Time AI Navigation in Minimally Invasive Surgery Room 3 Daichi Kitaguchi(Univ. of Tsukuba, Japan)
10:10~10:30 Intraoperative Assessment and AI-Assisted Coaching System in Hepatobiliary Surgery Room 3 Xin Wang(The Chinese Univ. of Hong Kong, Hong Kong)
13:50~14:10 Advanced Imaging Modalities and Differential Diagnosis: A Radiologist’s Perspective Room 3 차동익(성균관의대)
14:10~14:30 Risk Stratification and Indication for Surgical Resection: A Surgeon’s Perspective Room 3 한의수(가톨릭의대)
14:30~14:50 Minimally Invasive Approaches in the Management of Benign Liver Tumors Room 3 김경식(한양의대)
14:50~15:10 Surveillance after Surgery Outcomes and Recurrence: A Surgeon’s Perspective Room 3 박민수(경희의대)
07:30~07:45 Unmet Needs in Current Treatment of Chronic Hepatitis B Room 4A 문상이(동아의대)
07:45~08:00 Working Toward Functional Cure of Chronic Hepatitis B Room 4A 허정(부산의대)